This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Under-$10 Stocks Setting Up to Trade Higher

Response Genetics

Another under-$10 stock that's setting up to trigger a breakout trade is Response Genetics (RDGX), which is engaged in the research and development of innovative clinical diagnostic tests for cancer based on its proprietary technologies. This stock has been uptrending very strong for the last three months, with shares up a whopping 61%.

If you take a look at the chart for Response Genetics, you'll notice that this stock is just starting to trend above its 50-day moving average of $1.20 a share and volume is spiking dramatically to the upside. This action is quickly pushing shares of RGDX within range of triggering a near-term breakout trade.

Market players should now look for long-biased trades in RGDX once it breaks out above some near-term overhead resistance levels at $1.29 to $1.45 a share, and then once it clears $1.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 32,260 shares. If that breakout triggers soon, then RGDX will set up to re-test or possibly take out its next significant overhead resistance levels at $2 to $2.40 a share.

Traders can look to buy RGDX off any weakness as long as it's trending above its 50-day moving average of $1.20 a share, or as long as it's trending above $1.10 a share. One can also buy off strength once RGDX takes out $1.29 to $1.45 a share with volume and then simply use a stop that sits near its 50-day at $1.20 a share. I would add to either position once RGDX clears $1.60 a share with volume.


One under-$10 name that's trending very close to triggering a major breakout trade is Arqule (ARQL), which is a clinical-stage biotechnology company engaged in the research and development of innovative cancer therapeutics. This stock has been hit hard by the bears so far in 2012, with shares down by over 50%.

If you take a look at the chart for Arqule, you'll notice that this stock gapped down big in early October from $5 to $1.98 a share with massive downside volume. Following that move, shares of ARQL have entered a range bound trading pattern, with shares moving between $2.25 on the downside and $2.92 on the upside. Shares of ARQL are now starting to move within range of breaking out above the upper-end of its recent trading range.

3 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs